
Linklaters M&A and private equity partner Lev Loukhton has relocated to the firm’s New York office, marking the continued expansion of the New York office’s global M&A and private equity capabilities.
Lev Loukhton has decades of cross-border transactional experience to bear, representing domestic and multinational companies in mergers, acquisitions, divestitures and joint ventures, as well as on general corporate issues. He acts for companies and financial sponsors in transactions across a variety of sectors, including technology, media and telecoms (TMT), financial institutions, industrials and chemicals.
Related: Covington Nabs Former Linklaters Antitrust Chief
Lev Loukhton stated, “I am delighted to come back to New York. The office is dynamic and growing. I look forward to continuing to work in close collaboration with clients from my new base in New York to help them achieve their strategic objectives.”
Thomas McGrath, US Global Practice Head & Antitrust Partner, commented “We are thrilled to have Lev in the New York office. He brings significant expertise to help strengthen our corporate offering in the Americas by advising on high-stakes, complex deals in New York and globally.”
“Lev has been instrumental in growing our practice in Europe,” said Simon Branigan, Global Head of Corporate based in London, “and we are very excited that he has moved to the U.S. to enhance our growing corporate practice.”
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas